Parliamentary Panel Urges Doubling Ayushman Bharat Cover to Rs 10 Lakh to Protect Families from Catastrophic Care

NEW DELHI — In a major move aimed at reducing the financial burden of severe illnesses on vulnerable families, the Parliamentary Standing Committee on Health and Family Welfare has recommended doubling the insurance ceiling of the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY). In its 172nd report presented in July 2026, the committee urged the Indian government to raise the annual per-family cover from the current Rs 5 lakh to Rs 10 lakh. The panel argued that the skyrocketing costs of advanced medical treatments—such as organ transplants, complex cardiac procedures, and oncology immunotherapies—have made the existing eight-year-old limit inadequate for many beneficiaries. To ensure fiscal sustainability, the report suggests introducing targeted, high-cost treatment packages supported by pooled financing and negotiated hospital pricing.

Shifting Clinical Realities: Why Rs 5 Lakh is No Longer Enough

The current health insurance cap of Rs 5 lakh was established at the launch of the Ayushman Bharat scheme in 2018. Over the last eight years, the landscape of medicine has evolved rapidly. While basic secondary and tertiary care remain within this limit, modern medical advancements have outpaced historical reference pricing.

The committee’s findings emphasize that life-saving interventions—including newer biologics, precision oncology treatments, and minimally invasive cardiac surgeries—regularly exceed the Rs 5 lakh threshold. When a patient’s treatment cost crosses this cap, the family is forced to pay the remaining balance out of pocket. This financial deficit defeats the primary objective of the scheme: preventing medical bankruptcy. By elevating the ceiling to Rs 10 lakh, the panel aims to shield households from catastrophic health expenditures during advanced medical crises.

To put this into perspective, consider a hypothetical scenario where a patient requires a complex liver transplant costing Rs 12 lakh:

Note: The final household liability would still depend on specific negotiated package rates and co-payment rules, but the financial gap for the family shrinks substantially.

Strategic Reforms: Pooled Financing and Wider Eligibility

The recommended expansion goes beyond simply doubling the coverage number. The parliamentary panel proposed a structured approach to manage high-cost treatments effectively:

• Targeted High-Cost Packages: The committee suggested creating specialized packages for exceptionally expensive procedures. These would be sustained through pooled financing mechanisms, co-funding arrangements with state governments, and strictly negotiated rates with healthcare providers.

• Wider Demographic Eligibility: Building on prior legislative discussions, the panel revisited recommendations to widen the scheme’s safety net. This includes proposals to lower the age threshold to 60 years for specific senior citizen provisions (such as the Ayushman Vay Vandana initiative), ensuring a larger population of vulnerable older adults is protected.

• Performance-Linked Fund Releases: To optimize operational efficiency, the committee recommended linking central fund releases to the actual performance and implementation metrics of individual states.

Expert Perspectives: The Balance Between Access and Fiscal Reality

Public health analysts and policy experts view the recommendations as a necessary step forward for health equity, though they urge operational caution.

Independent health policy analysts note that expanding the coverage ceiling could significantly reduce medical impoverishment across India. However, they emphasize that a higher nominal cover is only half the battle. The long-term success of the expansion will depend entirely on rigid cost control, structured provider payment mechanisms, and aggressive monitoring to avoid “supplier-driven demand”—a scenario where hospitals might recommend unnecessary interventions simply because more insurance money is available.

From a fiscal standpoint, officials familiar with internal government estimates indicate that doubling the insurance cap alongside expanding the beneficiary base will carry a massive financial footprint. National Health Authority (NHA) data and subsequent policy analyses suggest that the fiscal impact could run into thousands of crores of rupees annually. Consequently, experts suggest that a phased rollout or a system that prioritizes specific, pre-authorized high-cost packages may be the most viable path forward for the government.

Public Health Implications and Operational Challenges

While the human benefit of a Rs 10 lakh cover is clear, implementing it requires navigating complex economic and administrative terrain.

1. The Fiscal Challenge

With financing shared between the central government and individual states, a sudden increase in claims costs could strain state budgets. Policymakers must figure out how to allocate additional annual funding without compromising other primary healthcare initiatives.

2. Preventing Moral Hazard and Fraud

Higher insurance ceilings inherently increase the risk of “upcoding” (billing for a more expensive condition than the patient actually has) or prolonged hospitalizations. To prevent abuse, the expansion must be coupled with evidence-based package rates, mandatory pre-authorizations, standardized clinical pathways, and routine medical audits.

3. Administrative Complexity

Negotiating subsidized pricing with corporate tertiary hospitals, pharmaceutical companies, and medical device manufacturers is highly complex. Creating a transparent framework that satisfies both private healthcare providers and state treasuries will determine whether the benefits actually reach patients at the bedside.

What This Means for Readers: Practical Takeaways

• For Patients and Families: If adopted by the Ministry of Health, families facing severe diagnoses will experience dramatically improved financial protection. However, because implementation will take time, families should stay informed about state-specific eligibility timelines and approved hospital networks.

• For Clinicians and Healthcare Providers: Medical institutions should prepare for a shift toward more tightly regulated clinical protocols. The inclusion of high-cost packages will likely bring standardized pre-authorization workflows and renegotiated reimbursement rates tied directly to quality compliance.

• For Policymakers: The panel’s report serves as a mandate to balance welfare expansion with economic discipline. Any increase in coverage must be paired with pooled procurement strategies and performance-driven state financing to ensure the system remains sustainable for years to come.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

1. Parliamentary Standing Committee on Health and Family Welfare: 172nd Report on Ayushman Bharat–PMJAY Expansion, presented July 2026.

2. The Times of India: “Panel recommends raising Ayushman Bharat cover to Rs 10 Lakh,” published July 7, 2026 (Summary of the 172nd Parliamentary Standing Committee Report).